New study reveals racial disparities in voice box-preserving cancer treatment

July 16, 2012

A new epidemiological study led by UC Davis researchers reveals significant racial disparities in the use of non-surgical larynx-preservation therapy for locally advanced laryngeal cancer.

A review of medical records between 1991 and 2008 from across the country reveals that over 80 percent of white patients received combined with chemotherapy that preserves the larynx, or voice box. Only 74.5 percent of African American patients received this same treatment, with the remainder undergoing surgery that removed the larynx altogether, a procedure that has a dramatic effect on quality of life.

Just published online in the American Medical Association's Archives of Otolaryngology - , the paper analyzes treatment trends among 5,385 white, black, Latino and with stage III and IV laryngeal cancers. Records were culled from the 's (NCI) Surveillance Epidemiology and End Results program, which collects information on , prevalence and survival from specific geographic areas representing 28 percent of the U.S. population.

"We believe that future research should focus on identifying and eliminating barriers to the use of larynx-preservation for all medically suitable patients, with a particular focus on black patients," says lead author Allen Chen, an assistant professor in the UC Davis Department of Radiation Oncology.

Non-surgical therapy using with concurrent chemotherapy confers a high rate of voice conservation without adversely affecting survival for selected patients diagnosed with locally advanced cancers of the larynx.

Before larynx-preserving treatment gained widespread acceptance in recent decades, the standard of care for essentially all patients with locally advanced laryngeal cancer was initial surgical removal of the larynx, called a total laryngectomy. These patients suffer from more , pain and depression than patients with an intact larynx. They often develop chronic shoulder pain and sleep disturbances, and they experience worse social functioning and isolation as a result of speech impairment and body disfigurement.

While researchers observed a marked disparity between the study's white and black populations, differences were less pronounced for the Latino and Asian groups, with 78 percent of Latinos and 75.6 percent of Asians receiving larynx-preserving treatment. The observed gap between whites and blacks may also be narrowing, as the use of larynx-preservation is increasing among black patients over time.

"Further studies are needed to elicit the root causes of the current treatment disparities between whites and blacks, but it seems likely that critical factors include income, education and insurance differences, along with a lack of access to appropriate radiation facilities," says Chen, who also serves as the UC Davis Department of 's residency training program director.

Chen points out that the best treatment facilities can be found at the nation's 41 NCI-designated comprehensive cancer centers, as these institutions feature not only the latest technologies but also in-depth counseling and therapy both for medical decision-making and post-treatment management.

"Larynx preservation requires close coordination of care involving multiple specialists, including radiation oncologists, medical oncologists, otolaryngologists, speech pathologists, swallowing therapists, dentists and nutritionists, among many others," he said. "Having all of these services available in centers such as the UC Davis Comprehensive Cancer Center makes treatment a lot more feasible for patients."

Explore further: Donor aortic graft improves reconstruction after partial laryngectomy

More information: Arch Otolaryngol Head Neck Surg. 2012:138[7]:644-649.

Related Stories

Donor aortic graft improves reconstruction after partial laryngectomy

May 21, 2012
Massachusetts General Hospital (MGH) surgeons have developed a new technique for reconstructing the larynx after surgery for advanced cancer. In the May Annals of Otology, Rhinology and Laryngology, they describe how this ...

Recommended for you

MRI contrast agent locates and distinguishes aggressive from slow-growing breast cancer

September 25, 2017
A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between aggressive and slow-growing ...

Researchers identify gene variants linked to a high-risk children's cancer

September 25, 2017
Pediatric researchers investigating the childhood cancer neuroblastoma have identified common gene variants that raise the risk of an aggressive form of that disease. The discovery may assist doctors in better diagnosing ...

Prostaglandin E1 inhibits leukemia stem cells

September 25, 2017
Two drugs, already approved for safe use in people, may be able to improve therapy for chronic myeloid leukemia (CML), a blood cancer that affects myeloid cells, according to results from a University of Iowa study in mice.

Cancer vaccines need to target T cells that can persist in the long fight against cancer

September 25, 2017
Cancer vaccines may need to better target T cells that can hold up to the long fight against cancer, scientists report.

Lung cancer treatment could be having negative health effect on hearts

September 25, 2017
Radiotherapy treatment for lung cancer could have a negative effect on the health of your heart new research has found.

Alternative splicing, an important mechanism for cancer

September 22, 2017
Cancer, which is one of the leading causes of death worldwide, arises from the disruption of essential mechanisms of the normal cell life cycle, such as replication control, DNA repair and cell death. Thanks to the advances ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.